 |
|
|
|
|
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Checler F. on PAPER: Deyts C. et al., 2012, The paper by Deyts and colleagues is of great interest. It shows that the C-terminal stubs... 15 Feb 2012.
|
|
|
 |
|
|
Checler F. on PAPER: Ring S. et al., 2007, Recommendation Only. 21 Aug 2007.
|
|
|
|
|
|
Checler F. on NEWS: Longevity Tied to Insulin Action in Brain, It is well established that p53 is an oncogene, many mutations on which are responsible for the... 23 Jul 2007.
|
|
|
|
|
|
Checler F. on PAPER: Zhang YW. et al., 2007, The β amyloid precursor protein (βAPP) undergoes several physiopathological cleavages among... 21 Jun 2007.
|
|
|
|
|
|
Checler F. on LIVE DISCUSSION: Gain or Loss of Function—Time to Shake up Assumptions on γ-Secretase in Alzheimer Disease?, The mechanisms by which mutations on presenilins may trigger or participate to AD pathology is a... 26 Apr 2006.
|
|
|
|
|
|
Checler F. on NEWS: AβPP Processing—Limping Along on Lipases, Several lines of evidence suggest that presenilins (PS) could contribute to both AβPP processing... 10 Feb 2006.
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
See our latest Webinar: 
